Offers newly developed, antigen affinity purified antibodies to accelerate your research. View product list by type, host, conjugation, clonality, by application or research area.
A biopharmaceutical company concentrating on novel orphan treatments for rare diseases. Their lead program, SBC-102, is an enzyme replacement therapy for LAL Deficiency.